https://www.polity.org.za
Deepening Democracy through Access to Information
Home / Legal Briefs / Other Briefs RSS ← Back
Close

Email this article

separate emails by commas, maximum limit of 4 addresses

Sponsored by

Close

Embed Video

CIPLA ordered by SCA to deliver its infringing Fiprotec spot on products to merial South Africa for destruction

CIPLA ordered by SCA to deliver its infringing Fiprotec spot on products to merial South Africa for destruction

22nd April 2016

SAVE THIS ARTICLE      EMAIL THIS ARTICLE

Font size: -+

On 1 April 2016, the Supreme Court of Appeal (SCA) upheld an appeal by Merial, Merial Limited and Merial South Africa (Pty) Ltd (Merial), against Cipla Vet (Pty) Ltd (Cipla).  The SCA confirmed that Merial’s patent for its Frontline Plus spot on product was valid and infringed by Cipla’s Fiprotec spot on products (“Fiprotec products”). The SCA accordingly ordered Cipla to cease all sales of Fiprotec products and to deliver up all Fiprotec products to Merial for destruction.  The SCA also ordered that there be an enquiry into the damages suffered by Merial as a result of Cipla’s infringing conduct.

The interdict and the order for delivery up of the infringing Fiprotec products are effective immediately. Cipla must therefore cease all sales of Fiprotec products and deliver up all infringing products under its control to Merial forthwith.

The patent in suit is for Merial’s Frontline Plus anti-parasitic treatment for dog and cats.  Frontline Plus is applied to a single spot on the skin of the animal and is effective in controlling both fleas and ticks usually by monthly treatments. The invention of the patent was directed at the spot-on formulation which allowed for this ease of application and conferred this protection on animals.

Merial’s Frontline Plus remains a leading animal health product globally with unsurpassed success. In 2008, Cipla entered the market with its competing Fiprotec product. Merial issued summons against Cipla and, although the Court of the Commissioner of Patents found in the first instance that Merial’s patent was valid, but not infringed, the SCA has now confirmed that the patent is valid and has found that Cipla’s Fiprotec product is infringing the patent.

At van Rooy of KISCH IP stated that this is a significant victory for Merial in a long battle against generic companies entering the market whilst the patents for the original products are still in force.

The full SCA judgment is available at the following link: http://www.justice.gov.za/sca/judgments/sca_2016/sca2016-057.pdf



Submitted by KISCH IP

Advertisement

 

To watch Creamer Media's latest video reports, click here
 
Advertisement

EMAIL THIS ARTICLE      SAVE THIS ARTICLE

To subscribe email subscriptions@creamermedia.co.za or click here
To advertise email advertising@creamermedia.co.za or click here

Comment Guidelines

About

Polity.org.za is a product of Creamer Media.
www.creamermedia.co.za

Other Creamer Media Products include:
Engineering News
Mining Weekly
Research Channel Africa

Read more

Subscriptions

We offer a variety of subscriptions to our Magazine, Website, PDF Reports and our photo library.

Subscriptions are available via the Creamer Media Store.

View store

Advertise

Advertising on Polity.org.za is an effective way to build and consolidate a company's profile among clients and prospective clients. Email advertising@creamermedia.co.za

View options
Free daily email newsletter Register Now